Central serous chorioretinopathy
MONDO:0018616Central serous chorioretinopathy is a disease that causes fluid to build up under the retina, the back part of the inner eye that sends sight information to the brain. The fluid leaks from thechoroid (theblood vessel layer under the retina). The cause of this condition is unknown but stress can be a risk factor. Signs and symptoms include dim and blurred blind spot in the center of vision, distortion of straight linesand seeingobjectsas smaller or farther away. Many cases of central serous chorioretinopathy improve without treatment after 1-2 months. Laser treatment may be an option for other individuals.
Also known as: CSC, CSCR, central serous retinopathy, central serous chorioretinopathy after bone marrow transplantation, central serous choroidopathy
21 clinical trials for this condition and its sub-types, 8 tagged with Central serous chorioretinopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Probiotics may speed recovery from eye disease, new study hopes
Disease control Recruiting nowThis study looks at whether gut bacteria are linked to central serous chorioretinopathy (CSC), an eye condition that causes fluid buildup and vision problems. Researchers will compare gut bacteria in 400 people with and without CSC. They will also give some participants a Bifidob…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New laser hope for eye fluid disorder
Disease control Recruiting nowThis study tests a low-energy laser treatment for central serous chorioretinopathy, an eye condition where fluid builds up under the retina. The 36 participants have not improved with standard medications. The laser aims to reduce fluid and improve vision by targeting the back of…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Eye fluid clues may predict who benefits from vision-saving injections
Knowledge-focused Recruiting nowThis study analyzes blood and aqueous humor (eye fluid) from 250 people with type 1 choroidal neovascularization—a cause of vision loss—and from controls without the condition. Researchers measure biomarker levels and check whether they correlate with how well patients respond to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC